United States (US) Female Contraceptive Market (2025-2031) | Analysis, Companies, Size & Revenue, Outlook, Value, Forecast, Competitive Landscape, Industry, Growth, Share, Trends, Segmentation

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Female Contraceptive Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Female Contraceptive Market - Industry Life Cycle

3.4 United States (US) Female Contraceptive Market - Porter's Five Forces

3.5 United States (US) Female Contraceptive Market Revenues & Volume Share, By Contraceptive Drugs, 2021 & 2031F

3.6 United States (US) Female Contraceptive Market Revenues & Volume Share, By Devices, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness about the importance of family planning and contraceptive methods among women.

4.2.2 Growing emphasis on women's reproductive health and rights.

4.2.3 Technological advancements leading to the development of more effective and convenient contraceptive options.

4.3 Market Restraints

4.3.1 Regulatory hurdles and stringent approval processes for new contraceptive products.

4.3.2 Social stigmas and cultural barriers associated with contraceptive use.

4.3.3 Increasing competition from alternative birth control methods such as long-acting reversible contraceptives (LARCs) and fertility awareness methods.

6.1 United States (US) Female Contraceptive Market, By Contraceptive Drugs

6.1.1 Overview and Analysis

6.1.2 United States (US) Female Contraceptive Market Revenues & Volume, By Contraceptive Drugs, 2021- 2031F

6.1.3 United States (US) Female Contraceptive Market Revenues & Volume, By Oral Contraceptives, 2021- 2031F

6.1.4 United States (US) Female Contraceptive Market Revenues & Volume, By Topical Contraceptives, 2021- 2031F

6.1.5 United States (US) Female Contraceptive Market Revenues & Volume, By Contraceptive Injections, 2021- 2031F

6.1.6 United States (US) Female Contraceptive Market Revenues & Volume, By Spermicides, 2021- 2031F

6.2 United States (US) Female Contraceptive Market, By Devices

6.2.1 Overview and Analysis

6.2.2 United States (US) Female Contraceptive Market Revenues & Volume, By Female Condoms, 2021- 2031F

6.2.3 United States (US) Female Contraceptive Market Revenues & Volume, By Diaphragms and Caps, 2021- 2031F

6.2.4 United States (US) Female Contraceptive Market Revenues & Volume, By Vaginal Rings, 2021- 2031F

6.2.5 United States (US) Female Contraceptive Market Revenues & Volume, By Contraceptive Sponges, 2021- 2031F

6.2.6 United States (US) Female Contraceptive Market Revenues & Volume, By Sub-dermal Contraceptive Implants, 2021- 2031F

6.2.7 United States (US) Female Contraceptive Market Revenues & Volume, By Intra-Uterine Contraceptive Devices (IUCDs), 2021- 2031F

7.1 United States (US) Female Contraceptive Market Export to Major Countries

7.2 United States (US) Female Contraceptive Market Imports from Major Countries

8.1 Percentage of women aged 15-49 using modern contraceptive methods.

8.2 Number of healthcare providers offering contraceptive counseling and services.

8.3 Research and development investment in innovative female contraceptive technologies.

9.1 United States (US) Female Contraceptive Market Opportunity Assessment, By Contraceptive Drugs, 2021 & 2031F

9.2 United States (US) Female Contraceptive Market Opportunity Assessment, By Devices, 2021 & 2031F

10.1 United States (US) Female Contraceptive Market Revenue Share, By Companies, 2024

10.2 United States (US) Female Contraceptive Market Competitive Benchmarking, By Operating and Technical Parameters